| Overcoming Immunological Resistance Enhances the Efficacy of a Novel anti-tMUC1 CAR T Cell Treatment Against Pancreatic Ductal Adenocarcinoma M Yazdanifar, R Zhou, P Grover, C Williams, M Bose, LJ Moore, S Wu, ... Cells, 642934, 2019 | 61 | 2019 |
| Potential of Anti-MUC1 Antibodies as a Targeted Therapy for Gastrointestinal Cancers M Bose, P Mukherjee Vaccines 8 (4), 1-21, 2020 | 56 | 2020 |
| Microbe–MUC1 crosstalk in cancer-associated infections M Bose, P Mukherjee Trends in molecular medicine 26 (3), 324-336, 2020 | 44 | 2020 |
| Targeting tumor-associated MUC1 overcomes anoikis-resistance in pancreatic cancer M Bose, A Sanders, C De, R Zhou, P Lala, S Shwartz, B Mitra, C Brouwer, ... Translational Research 253, 41-56, 2023 | 43 | 2023 |
| Mucin signature as a potential tool to predict susceptibility to COVID‐19 M Bose, B Mitra, P Mukherjee Physiological reports 9 (1), e14701, 2021 | 34 | 2021 |
| Role of microbiome in modulating immune responses in cancer M Bose, P Mukherjee Mediators of Inflammation 2019 (1), 4107917, 2019 | 34 | 2019 |
| Overexpression of MUC1 induces non-canonical TGF-beta signaling in Pancreatic Ductal Adenocarcinoma M Bose, P Grover, A Sanders, R Zhou, M Ahmad, S Shwartz, P Lala, ... Frontiers in Cell and Developmental Biology, 39, 2022 | 20 | 2022 |
| Repression of MUC1 promotes expansion and suppressive function of myeloid-derived suppressor cells in pancreatic and breast cancer murine models M Sahraei, M Bose, JA Sanders, C De, L DasRoy, S Nath, CR Brouwer, ... International journal of molecular sciences 22 (11), 5587, 2021 | 18 | 2021 |
| A novel antibody blocks anti-apoptotic activity of MUC1 in Pancreatic Ductal Adenocarcinoma cell lines M Bose, P Mukherjee Cancer Research https://doi.org/10.1158/1538-7445 79 (Issue 13), Supplement …, 2019 | 9* | 2019 |
| Preferentially expressed antigen in melanoma is a multifaceted cancer testis antigen with diverse roles as a biomarker and therapeutic target M Bose International Journal of Translational Medicine 3 (3), 334-359, 2023 | 7 | 2023 |
| Molecular crosstalk between MUC1 and STAT3 influences the anti-proliferative effect of Napabucasin in epithelial cancers M Bose, A Sanders, A Handa, A Vora, MR Cardona, C Brouwer, ... Scientific Reports 14 (1), 3178, 2024 | 4 | 2024 |
| Repression of MUC1 promotes expansion and suppressive function of myeloid-derived suppressor cells in pancreatic ductal adenocarcinoma and breast cancer murine models S Mahnaz, LD Roy, M Bose, C De, S Nath, P Mukherjee bioRxiv, 2020.12. 07.415299, 2020 | 2 | 2020 |
| MUC1 confers sensitivity to STAT-3 inhibitor napabucasin in pancreatic ductal adenocarcinoma cells M Bose, A Vora, T Colleton, P Mukherjee Cancer Research 80 (16_Supplement), 1837-1837, 2020 | 2 | 2020 |
| PRAME Is a Multifaceted Cancer Testis Antigen with Diverse Roles as a Biomarker and Therapeutic Target M Bose | 1 | 2023 |
| Tumor-Associated MUC1 Regulates TGF-β Signaling and Function in Pancreatic Ductal Adenocarcinoma P Grover, S Nath, M Bose, AJ Sanders, C Brouwer, Nitika, R Zhou, ... bioRxiv, 2020.04. 29.068577, 2020 | 1 | 2020 |
| Abrogating the Oncogenic Signaling Associated with Tumor MUC1 in Pancreatic Ductal Adenocarcinoma M Bose The University of North Carolina at Charlotte, 2022 | | 2022 |
| Reply to the letter from Dr. Pirjo Pärnänen et al M Bose, B Mitra, P Mukherjee Physiological Reports 9 (3), e14743, 2021 | | 2021 |
Cory R. BrouwerProfessor of Bioinformatics and Genomics, UNC Charlotteایمیل تأیید شده در technicaldocs.com
